Elephant Hawk logo Elephant Hawk ← Chrysalis library Start Tools Log In Context Brief

🇨🇳 China Deep-Dive — FDA Filings Analysis

What Chinese sponsors are clearing through US FDA: who, where, what, and whether they're competing legitimately or arbitraging predicate devices.
Data window: 5y for clearances, 3y for recalls, 12mo for momentum signals. Source: openFDA + FDA Establishment Registration & Listing. Generated: 2026-06-06 23:30.
Free edition · Published by Elephant Hawk — elephanthawk.com/tools

Contents

  1. TL;DR
  2. Strategic Synthesis
  3. Volume & Growth
  4. Two-Tier Sponsor Pattern
  5. Top Chinese Sponsors
  6. Geographic Concentration
  7. Specialty Focus
  8. Copy-Signal Codes
  9. Predicate Citation Graph (DIRECT IP-COPY EVIDENCE)
  10. Safety & Recall Profile

TL;DR

5y CN clearances
3,333
1,472 unique sponsors
Last 12mo
556
34.0% of all foreign clearances
One-shot sponsors
865
cleared 1 product only
Serious players
41
cleared 10+ products
The structure of the China FDA presence is bimodal. A long tail of 865 firms got cleared on a single product — commodity / pandemic-era arbitrage (masks, gloves, thermometers). A small head of 41 firms (2.8% of total) are building real US portfolios (Mindray, United Imaging, Edan, Micro-Tech). The two need very different competitive responses.

Synthesis

The concentration data reveals a bifurcated Chinese strategy in the US market: while 865 sponsors (59% of the total) have cleared only a single product—suggesting opportunistic commodity plays or post-pandemic pivots—a cohort of 41 sponsors with 10+ clearances commands serious attention. Shanghai United Imaging Healthcare Co., Ltd. (60 clearances) and Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (52 clearances) are not arbitrageurs but credible global MedTech firms building systematic portfolios across imaging, monitoring, and critical-care platforms. Promisemed Hangzhou Meditech Co., Ltd. with 31 clearances occupies a middle tier, demonstrating repeatability without yet matching the R&D depth of the top two. The 556 clearances in the trailing twelve months and 34% share of all foreign clearances signal that Chinese sponsors are no longer niche entrants but structural competitors with both capital and regulatory expertise. The recall record—169 incidents over three years with 25 Class I events—is material but not disqualifying when scaled against 3,333 clearances; it reflects quality-system immaturity more than reckless behavior, and the leading firms' recall rates appear lower than the long-tail commodity players.

The product-code distribution exposes a deliberate two-track approach: high-volume commoditization of low-barrier codes and selective encroachment into established US device categories. Chinese dominance in FXX (Mask, Surgical) with 260 clearances versus 85 US and LZA (Polymer Patient Examination Glove) with 180 versus 79 US reflects pandemic-era supply-chain opportunism and cost arbitrage in consumables where IP protection is thin and substantial equivalence is trivial. More strategically significant is the pattern in DXN (System, Measurement, Blood-Pressure, Non-Invasive) with 122 Chinese clearances against only 15 US and FLL (Continuous Measurement Thermometer) with 96 Chinese versus 13 US—these ratios suggest Chinese sponsors are not merely copying mature US products but flooding categories where incumbent US innovation has stalled or where incumbents have ceded the mid-market to focus on premium hospital segments. The GEX (Powered Laser Surgical Instrument) code, with 125 Chinese clearances versus 99 US, sits at the boundary: it indicates Chinese firms are now filing in capital-equipment categories traditionally defended by US and European patent portfolios, likely through design-around engineering or by targeting predicate devices whose patent cliffs have passed. This is legitimate substantial-equivalence process under FDA rules, but the velocity and code concentration point to coordinated IP mapping and a strategy of predicate-hopping that systematically erodes incumbent moats without direct infringement.

Volume & Growth

Year-over-year 510(k) clearance count for China-headquartered sponsors. The 2021 spike reflects pandemic-driven mask/glove/oximeter clearances. Steady-state since: ~500-600 clearances/year from 340-470 distinct sponsors.

YearClearancesUnique sponsorsVolume
2020 301 203
2021 625 470
2022 613 409
2023 509 351
2024 509 344
2025 535 344
2026 241 174

Two-Tier Sponsor Pattern

Of the 1,472 unique Chinese sponsors over 5 years, 865 cleared exactly ONE product — the commodity/arbitrage tier. Only 41 firms have built portfolios of 10+ products — the global-firm tier.

Top 30 Chinese Sponsors by 5y Activity

SponsorCity5y Clearances Last 12moDistinct codesMost recent
Shanghai United Imaging Healthcare Co., Ltd. 60 15 9 2026-05-22
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 52 12 8 2026-05-20
Promisemed Hangzhou Meditech Co., Ltd. 31 4 10 2026-05-12
Micro-Tech (Nanjing) Co., Ltd. 23 4 16 2026-04-24
Shenzhen Ulike Smart Electronics Co., Ltd. 23 7 4 2026-05-21
Shenzhen Kaiyan Medical Equipment Co., Ltd. 22 12 4 2026-05-04
Edan Instruments, Inc. 21 4 9 2026-02-09
Shenzhen TPH Technology Co., Ltd. 20 8 1 2026-05-21
Hunan Vathin Medical Instrument Co., Ltd. 17 2 5 2025-07-25
Winner Medical Co., Ltd. 17 2 4 2025-10-10
Iray Technology Taicang , Ltd. 16 0 3 2023-01-17
Aidite (Qinhuangdao) Technology Co., Ltd. 16 2 5 2026-04-06
Zhejiang Innuovo Rehabilitation Devices Co.,Ltd 16 1 2 2026-04-20
Hangzhou AGS MedTech Co., Ltd. 15 2 10 2026-04-08
Guangdong Kingfa Sci. & Tech.Co., Ltd. 14 0 4 2024-07-29
Shenzhen AOJ Medical Technology Co., Ltd. 14 2 3 2026-04-01
Huizhou Foryou Medical Devices Co., Ltd. 13 1 3 2025-11-19
Andon Health Co, Ltd. 13 1 5 2025-08-04
Hangzhou AllTest Biotech Co., Ltd. 13 3 9 2026-04-30
Rizhao Huge Biomaterials Company, Ltd. 13 2 5 2025-12-12
Guangdong Transtek Medical Electronics Co., Ltd. 12 0 2 2025-01-30
Joytech Healthcare Co. , Ltd. 12 4 4 2026-04-28
Shanghai AnQing Medical Instrument Co., Ltd. 12 4 5 2026-02-26
Tianjin Huahong Technology Co., Ltd. 12 4 3 2026-03-31
Philips Healthcare (Suzhou) Co., Ltd. 12 2 4 2026-03-23
Unimed Medical Supplies, Inc. 12 8 3 2026-04-14
Jiangsu Caina Medical Co.,Ltd 11 0 9 2024-03-07
Shanghai Apolo Medical Technology Co., Ltd. 11 3 5 2026-05-04
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd. 11 0 5 2024-03-19
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. 11 3 4 2026-03-05

Geographic Concentration

Where in China the sponsors are headquartered. The dominant clusters reveal which Chinese industrial centers are most aggressive at US market entry.

City / Province5y ClearancesUnique sponsorsVolume
3333 1472

Specialty Focus

Which medical specialties Chinese sponsors are concentrating in. General/Plastic Surgery dominance reflects the volume tier (surgical masks, gloves, lasers, light-based hair removal). Radiology and Cardiovascular reflect the serious-firm tier (Mindray, United Imaging, Edan).

Specialty5y ClearancesUnique sponsorsLast 12mo
General, Plastic Surgery 823 490 135
General Hospital 493 288 19
Cardiovascular 338 152 67
Radiology 328 96 58
Physical Medicine 279 156 71
Gastroenterology, Urology 272 104 55
Dental 187 98 33
Obstetrics/Gynecology 144 76 45
Neurology 126 79 16
Anesthesiology 66 45 17
Unknown 65 36 11
Clinical Chemistry 52 33 5

Copy-Signal Codes

What you're seeing. Product codes where US incumbents have 10+ cleared devices AND Chinese sponsors have 10+ cleared devices in the same code. The 510(k) substantial-equivalence pathway requires citing a US predicate — if a Chinese sponsor cleared under one of these codes, they're effectively saying "my device is the same as the US incumbents'." Whether that's legitimate substantial equivalence or IP capture depends on the underlying patent landscape (which openFDA can't tell you — USPTO Assignment + FOIA on the 510(k) Summary is needed for the next layer).
CodeDeviceClassSpecialty US clearancesUS sponsors CN clearancesCN sponsorsCN last 12mo CN/US ratio
FXX Mask, Surgical II General, Plastic Surgery 85 70 260 227 3 3.06
LZA Polymer Patient Examination Glove I General Hospital 79 37 180 129 1 2.28
GEX Powered Laser Surgical Instrument II General, Plastic Surgery 99 54 125 62 43 1.26
DXN System, Measurement, Blood-Pressure, Non-Invasive II Cardiovascular 15 12 122 53 24 8.13
FLL Continuous Measurement Thermometer II General Hospital 13 11 96 68 3 7.38
IYN System, Imaging, Pulsed Doppler, Ultrasonic II Radiology 144 30 92 24 16 0.64
NUH Stimulator, Nerve, Transcutaneous, Over-The-Counter II Neurology 12 12 68 41 7 5.67
HGX Pump, Breast, Powered II Obstetrics/Gynecology 20 8 68 25 25 3.40
OHS Light Based Over The Counter Wrinkle Reduction II General, Plastic Surgery 21 13 64 41 33 3.05
DQA Oximeter II Cardiovascular 22 16 56 37 12 2.55
IRP Massager, Powered Inflatable Tube II Physical Medicine 21 16 48 31 10 2.29
EIH Powder, Porcelain II Dental 25 11 44 25 4 1.76
FYA Gown, Surgical II General, Plastic Surgery 18 13 44 38 3 2.44
FMI Needle, Hypodermic, Single Lumen II General Hospital 27 17 38 16 3 1.41
FMF Syringe, Piston II General Hospital 47 31 37 22 1 0.79
GEI Electrosurgical, Cutting & Coagulation & Accessories II General, Plastic Surgery 180 88 33 24 5 0.18
FRO Dressing, Wound, Drug Unknown 43 35 33 12 4 0.77
LNH System, Nuclear Magnetic Resonance Imaging II Radiology 80 29 31 9 8 0.39
NGX Stimulator, Muscle, Powered, For Muscle Conditioning II Physical Medicine 10 10 27 19 3 2.70
GCJ Laparoscope, General & Plastic Surgery II Gastroenterology, Urology 84 42 27 18 8 0.32

Reading the patterns

Predicate Citation Graph

What you're seeing. The 510(k) Summary document for each clearance lists the prior K-numbers cited as the "substantial equivalence" basis. Chinese sponsors literally state in their FDA filings: "my device is the same as US device K123456 made by Company X." This is the direct, document-grade evidence of predicate use. Section H above showed the pattern statistically; this section names the specific US incumbents whose devices are most frequently cited as the basis for Chinese clearances.
CN clearances analyzed
2,882
of 3,333 CN clearances
CN filings with citations
2,772
Total predicate citations
5,266
Unique predicates cited
2,786

⚡ Counterintuitive finding: Chinese filers cite OTHER CHINESE filers as predicates more than they cite US incumbents

The country distribution of resolvable predicates (predicates we can match against our 5-year warehouse — 42.7% of total CN-source citations resolve):

Predicate's HQ countryDistinct CN filers citingTotal citations
CN 1088 1474
US 227 258
KR 43 47
NL 24 28
MY 25 25
DE 20 21
IT 17 17
FR 15 15
CH 15 15
TW 13 13
DK 10 13
JP 11 13
GB 11 11
IL 11 11
CA 8 9
Read this carefully: The Chinese FDA ecosystem is largely self-referential. When a Chinese sponsor needs to demonstrate substantial equivalence for FDA clearance, they most often cite an earlier Chinese sponsor's already-cleared device, not a US incumbent. This means firms like Shenzhen Mindray and Shanghai United Imaging Healthcare have become predicate anchors — their early clearances unlock the path for dozens of smaller Chinese firms behind them. The "copy US IP" thesis is real but secondary; the bigger pattern is a Chinese-internal flywheel where established CN players legitimize the long tail.

Top 30 predicate anchors (any country) cited by CN filers

Most-cited predicates regardless of HQ. The dominance of Chinese names tells the ecosystem-flywheel story.

Sponsor (cited as predicate)HQ country Cited by CN filersTotal citations Codes touched
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. CN 50 116 BSZ, CBK, IYN, MHX, MSX, MWI
Shanghai United Imaging Healthcare Co., Ltd. CN 42 83 IZL, JAK, KPR, KPS, LLZ, LNH, OUO, QIH
Zhejiang Innuovo Rehabilitation Devices Co.,Ltd CN 32 32 INI, ITI
Shenzhen Ulike Smart Electronics Co., Ltd. CN 28 38 OHS, OHT
Iray Technology Taicang , Ltd. CN 22 27 MQB, MUH
Light Tree Ventures Europe B.V. NL 19 21 OAP, OHS, OKJ, OLP
Guangdong Kingfa Sci. & Tech.Co., Ltd. CN 17 18 FXX, LZA
Shenzhen TPH Technology Co., Ltd. CN 16 17 HGX
Guangdong Newdermo Biotech Co., Ltd. CN 15 15 OHS
Shenzhen Kaiyan Medical Equipment Co., Ltd. CN 14 16 OAP, OHS
Tianjin Huahong Technology Co., Ltd. CN 14 15 FMI, FMK, QRL
Edan Instruments, Inc. CN 13 18 DPS, DXN, IYN, MHX, MWI
Promisemed Hangzhou Meditech Co., Ltd. CN 12 14 FMF, FMI, FMK, KNW, PTI
Hunan Vathin Medical Instrument Co., Ltd. CN 12 13 EOB, EOQ, FED, FGB
Hangzhou AllTest Biotech Co., Ltd. CN 12 13 DJG, DKZ, JHI, NFT, NGL
Shenzhen Ionka Medical Technology Co., Ltd. CN 11 11 OHT, ONF
Shenzhen Mindray Bio-Meidcal Electronics Co., Ltd. CN 11 11 IYN, MWI
Ambu A/S DK 10 13 CBI, EOQ, FAJ
Shanghai Apolo Medical Technology Co., Ltd. CN 10 12 GEX, ONF, ONG, PKT
Microlife Intellectual Property GmbH CH 10 10 DXN, FLL
Shenzhen Fansizhe Science and Technology Co., Ltd. CN 10 10 OHT
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. CN 10 10 CAW, DQA, DXN, FLL
Siemens Medical Solutions USA, Inc. US 9 14 JAK, KPR, LLZ, LNH, QKB
Joytech Healthcare Co. , Ltd. CN 9 9 CAF, DXN, FLL, HGX
Shenzhen Sungpo Hi-Tech Electronic Co., Ltd. CN 9 9 OHS
Shenzhen Beauty Every Moment Intelligent Electric Co., Ltd. CN 9 9 OHT
Dongguan Boyuan Intelligent Technology Co.,Ltd CN 9 9 OHS, OHT
Shanghai AnQing Medical Instrument Co., Ltd. CN 8 12 EOQ, FGB
Guangzhou Red Pine Medical Instrument Co., Ltd. CN 8 10 FAJ, FET, FGB, HIH
Winner Medical Co., Ltd. CN 8 9 FRO, FXX, FYA, KGN

Top US-specifically cited predicates — the original "CN copying US IP" pattern

Filtered to just US incumbents whose 510(k) clearances appear as cited predicates in Chinese 510(k) submissions. This is the direct evidence of US-to-CN predicate use.

US sponsor (cited as predicate) Cited by CN filersTotal citations Codes touched
Siemens Medical Solutions USA, Inc. 9 14 JAK, KPR, LLZ, LNH, QKB
Mexpo International, Inc. 7 7 FXX
Medline Industires, Inc. 7 7 LZA, LZC
Demetech Corporation 7 7 FXX
Biophotas, Inc. 5 5 OAP, OLI
Inogen, Inc. 5 5 CAW
Alma Lasers, Inc. 5 5 GEI, GEX
Raja Trading Company, Inc. 5 5 GEX, NFO
Varian Medical Systems, Inc. 4 5 GEH, IYE
GE Medical Systems Ultrasound and Primary Care Diagnostics 4 4 ITX, IYN
Ge Healthcare (Ge Medical Systems, LLC) 4 4 LNH
CC Wellness, LLC 3 3 NUC
Roche Diabetes Care, Inc. 3 3 QRL
Marci Beauty, Inc. 3 3 OLP
Medline Industries, Inc. 3 3 IPF, KGO, LZA
Butterfly Network, Inc. 3 3 IYN
Sharkninja Operating, LLC 3 3 OHS
Zenith Technical Innovations 3 3 IRP
Theragun, Inc. 3 3 IRP, OHS
Omec Medical, Inc. 3 3 GCJ
ABBOTT MEDICAL 2 4 DQK, OBJ
Xtreem Pulse 2 3 NFO
Unisources Group, LLC 2 2 FXX
Manamed, Inc. 2 2 IMI, JOW
NormaTec Industries, LP 2 2 IRP
Willow Innovations, Inc. 2 2 HGX
Healgen Scientific,, LLC 2 2 LJX, NGL
Therabody, Inc. 2 2 IRP
Ansell Healthcare Products, LLC 2 2 LZA
Eclipse Medcorp, LLC 2 2 FMI, QAI

Product codes where many CN filers cite many US predicates

These are the categories where the predicate-citation graph is dense — multiple Chinese sponsors each citing multiple distinct US predicates. The most active "predicate arbitrage" categories.

CodeDevice CN filersDistinct US predicates cited Total citations
FXX Mask, Surgical 19 5 19
OHS Light Based Over The Counter Wrinkle Reduction 14 9 15
LZA Polymer Patient Examination Glove 12 6 12
GEX Powered Laser Surgical Instrument 10 6 10
IYN System, Imaging, Pulsed Doppler, Ultrasonic 9 8 12
IRP Massager, Powered Inflatable Tube 9 5 10
LNH System, Nuclear Magnetic Resonance Imaging 7 8 11
OAP Laser, Comb, Hair 7 7 10
CAW Generator, Oxygen, Portable 5 3 6
GCJ Laparoscope, General & Plastic Surgery 5 4 6
LLZ System, Image Processing, Radiological 5 3 5
KPR System, X-Ray, Stationary 4 4 5
NUC Lubricant, Personal 4 2 4
NXC Aligner, Sequential 4 4 4
NFO Stimulator, Transcutaneous Electrical, Aesthetic Purposes 3 4 5
HIH Hysteroscope (And Accessories) 3 3 4
FLL Continuous Measurement Thermometer 3 2 3
GXY Electrode, Cutaneous 3 3 3

Source: each citation extracted from the 510(k) Summary PDF on FDA's accessdata.fda.gov (cdrh_docs). Citations represent K-number references in the document — most are actual predicate-device declarations, some are background/comparative references. Manual spot-check recommended for the highest-stakes findings.

Safety & Recall Profile

Recall enforcement actions against China-located firms over 3 years. 218 total recalls, 32 Class I (most serious), 33 unique firms. This is the safety-quality signal — and partly indicates which firms FDA is actively scrutinizing.

FirmTotal RecallsClass IMost recent
Jiangsu Shenli Medical Production Co., Ltd. 87 0 2024-04-05
GE Healthcare (China) Co., Ltd. 24 0 2025-01-31
GE Medical Systems China Co., Ltd. 21 18 2025-11-14
Shanghai United Imaging Healthcare Co., Ltd. 19 0 2023-03-01
Changchun Wancheng Bio-Electron Co., Ltd. 11 0 2025-11-22
Chengdu Ai Qin E-commerce Co., Ltd 7 0 2020-06-23
Zhejiang Kindly Medical Devices Co., Ltd. 6 0 2021-08-24
Flexicare Medical (Dongguan) Ltd. 6 6 2025-07-11
Philips Healthcare (Suzhou) Co., Ltd. 3 0 2025-12-03
FENG CHUN YUAN MEDICAL EQUIPMENT (SHENZHEN)CO.,LTD 3 0 2024-06-26
Haimen Shengbang Laboratory Equipment Co. Ltd. 3 3 2022-07-12
Guangdong Haiou Medical Apparatus Co., Ltd 2 0 2022-06-10

China-based Clinical Trials

Studies with at least one China location, last 5y.

NCT Title Sponsor Status Phase Started N Results
NCT07399574 Diagnostic Accuracy of A Diquat Quantitative Detection Kit and A Portable Mass Spectrometry System for Quantifying Diquat Concentrations in Human Blood Samples The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School Not Yet Recruiting 2026-09-01 60
NCT07627685 Prospective Study on the Effectiveness and Safety of Bi-polar Pulse-field Tip-catheter Ablation for Atrial Fibrillation in China(POTENTIAL-AF) Beijing Anzhen Hospital Not Yet Recruiting 2026-09-01 30,000
NCT07593833 Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection Tongji Hospital Not Yet Recruiting 2026-07-01 1,000
NCT07594249 Shear Wave Elastography of Peripheral Nerves for Early Diagnosis of ICU-acquired Weakness First Affiliated Hospital of Wannan Medical College Not Yet Recruiting 2026-07-01 98
NCT07617298 EIT Evaluation of the Impact of Inhaled Nitric Oxide on Ventilation/Perfusion Mismatch in ARDS Patients Receiving Noninvasive Respiratory Support Ming Zhong Not Yet Recruiting 2026-06-30 40
NCT07624318 Trop2 NMR Concordance Study AstraZeneca Not Yet Recruiting 2026-06-15 3,400
NCT07544654 DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy Boehringer Ingelheim Not Yet Recruiting PHASE3 2026-06-15 390
NCT07604129 Transcranial Sonography and Machine Learning for Schizophrenia Identification Taizhou Second People's Hospital Not Yet Recruiting 2026-06-15 200
NCT07626229 Domain-Specific Large Language Model Assistance for Emergency Neurological Diagnosis and Treatment(DEMAND) Capital Medical University Not Yet Recruiting NA 2026-06-02 1,360
NCT07613242 Multimodal Assisted Diagnosis for Pediatric Respiratory Diseases Using Questionnaires, Cough Sounds, and Breath Sounds Shanghai Children's Medical Center Not Yet Recruiting 2026-06-01 1,400
NCT07616440 Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting NA 2026-06-01 20
NCT07616323 Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas West China Hospital Not Yet Recruiting 2026-06-01 70
NCT07620769 Safety and Efficacy Evaluation of the Radiofrequency Therapeutic Device for the Treatment of Atrophic Acne Scars CLASSYS Inc. Not Yet Recruiting NA 2026-06-01 252
NCT07620457 Spectral Precise Image Study for Coronary Artery Philips Clinical & Medical Affairs Global Not Yet Recruiting 2026-06-01 200
NCT07622771 Neoadjuvant Radiotherapy Combined With NALIRIFOX and Adebrelimab in pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Randomized, Phase II Clinical Trial Sun Yat-sen University Not Yet Recruiting PHASE2 2026-06-01 84
NCT07622576 A Comparative Study of the Efficacy of AR Based Amblyopia Training Therapy and Occlusion Therapy in Older Children and Adults With Amblyopia Second Affiliated Hospital, School of Medicine, Zhejiang University Not Yet Recruiting NA 2026-06-01 60
NCT07600125 Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers Xijing Hospital Not Yet Recruiting 2026-06-01 5,000
NCT07601191 AutoFUSE or First-Trimester Ultrasound Scan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Not Yet Recruiting NA 2026-06-01 1,000
NCT07618936 Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients Tianjin Medical University Recruiting 2026-06-01 500
NCT07590336 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma Peking Union Medical College Hospital Not Yet Recruiting PHASE1 / PHASE2 2026-06-01 100
NCT07620626 Real-World Study of Woven EndoBridge for Intracranial Aneurysm Treatment Xuanwu Hospital, Beijing Not Yet Recruiting 2026-06-01 1,000
NCT07628478 Effects of Blood Flow Restriction Training on Body Composition and Maximal Strength in Military Personnel Yang Liu Recruiting NA 2026-06-01 36
NCT07618793 Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma zhang yi Not Yet Recruiting PHASE2 2026-06-01 60
NCT07603700 STRATEGY-PE: Real-World Treatment Strategies for Intermediate-High Risk Pulmonary Embolism Nanjing First Hospital, Nanjing Medical University Not Yet Recruiting 2026-06-01 1,300
NCT06826469 The Efficacy and Safety of Task-state-based Temporal Interference Stimulation (TI) in the Treatment of Patients With Depression First Affiliated Hospital of Zhejiang University Not Yet Recruiting NA 2026-06-01 43
NCT07620444 Spectral Precise Image-Colon Cancer Philips Clinical & Medical Affairs Global Not Yet Recruiting 2026-06-01 100
NCT07574502 Transcutaneous Electrical Acustimulation on Postoperative Bowel Function Recovery in Elderly Patients Sir Run Run Shaw Hospital Not Yet Recruiting NA 2026-06-01 190
NCT07613424 A Study of MET Concordance and Gene Profiling in 1L NSCLC (Genomet) AstraZeneca Not Yet Recruiting NA 2026-05-31 1,000
NCT07607236 Muscle Ultrasound for Sarcopenia Assessment in Kidney Transplant Recipients Sichuan Provincial People's Hospital Not Yet Recruiting 2026-05-30 140
NCT07590284 Sonazoid CEUS for Early HCC Surveillance Tianjin Third Central Hospital Not Yet Recruiting NA 2026-05-30 556
NCT07612501 Efficacy and Safety of Transcranial Temporal Interference Stimulation for Depression Yonggui Yuan Not Yet Recruiting NA 2026-05-30 60
NCT07601997 Safety and Feasibility of Transcatheter Injectable Hydrogel in Acute STEMI Reperfusion Injury (REFINE Study) Myomed Technology (Shaoxing) Co., Ltd. Not Yet Recruiting NA 2026-05-30 20
NCT07596134 Multimodal Thermal Therapy With Targeted and Immunotherapy for Untreated Unresectable HCC Zhejiang University Not Yet Recruiting NA 2026-05-25 166
NCT07625748 Transcranial Temporal Interference Stimulation for Children With Autism Spectrum Disorders Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Recruiting NA 2026-05-25 16
NCT07604948 Effect of Ischemic Preconditioning on Lower Extremity Motor Ability and Recovery in Basketball Players During Post-Match Recovery Period Guangzhou Sport University Recruiting NA 2026-05-22 34
NCT07625540 Subthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's Disease Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting NA 2026-05-20 32
NCT07625007 Shortwave Intervention for Diabetic Peripheral Neuropathy: A Randomized, Single-Blind, Sham-Controlled Trial(SIDPN) Chongqing Medical University Recruiting NA 2026-05-20 202
NCT07483359 Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus First Hospital of China Medical University Recruiting PHASE2 2026-05-20 38
NCT07612774 CAPER-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS West China Hospital Recruiting PHASE4 2026-05-19 233
NCT07524699 A Study About Remote and Local Liver Surgery Tongji Hospital Not Yet Recruiting NA 2026-05-16 148

Publications from China-based Authors

Papers with affiliations in China or major Chinese cities, last 5y.

PMID Title Journal Authors Date Why
42207915 · DOI AI-assisted teams outperform AI-led teams but not human-only teams in assessing research reproducibility in quantitative social science. Proceedings of the National Academy of Sciences of the United States of America A Castillo Alvarez G, Abdelhady M, Abdelmoula Y, Aguirre T et al. 2026-06-02 Sponsor
42216631 · DOI SNR-Enhanced Whole-Brain Chemical Exchange Saturation Transfer Imaging by Optimized Variable Flip Angles. Magnetic resonance in medicine Dai Z, Hsu YC, Lu S, Su C et al. 2026-05-30 Sponsor
41863923 · DOI Binding characteristics and mechanisms underlying the enhanced stability of anthocyanins by proteins screened with molecular docking. Food chemistry He Y, Li B, Li Z, Quintana R et al. 2026-05-30 Sponsor
42212698 · DOI Near-point-of-care diagnosis of tuberculosis with LyocartE MTB Assay: a multicentre diagnostic accuracy study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Jing W, Li H, Li L, Ma X et al. 2026-05-29 Sponsor+KW
42213369 · DOI Prognosis and risk stratification in first-presentation myocardial infarction with nonobstructive coronary arteries using stress cardiac MRI. Insights into imaging Guo H, Li H, Li K, Long Q et al. 2026-05-29 Sponsor
42216194 · DOI Comparison of linear and angular cephalometric measurements in CBCT using semi-automated software and artificial intelligence-generated cephalograms. BMC oral health Aksoy S, Ersalıcı I, Ezhov M, Gusarev M et al. 2026-05-29 Sponsor
42213841 · DOI Contrast-sparing CT using renal-clearable gold nanoclusters for early spatial mapping of renal dysfunction. Science advances Caravan P, Catalano OA, Li D, Ma H et al. 2026-05-29 Sponsor
42216007 · DOI Long-term exposure to polystyrene microplastics exacerbates seizure symptoms via lipid metabolic disruption and ferroptosis: insights from multi-omics analyses. Journal of nanobiotechnology Deng X, Dou J, Hu S, Liu Y et al. 2026-05-29 Sponsor
42215867 · DOI AARS1 promotes diabetic kidney disease through rewiring Akt and NF-κB signaling to suppress autophagy and sustain inflammation. Cellular & molecular biology letters Agborbesong E, Guan C, Li X, Mou S et al. 2026-05-29 Sponsor
42214405 · DOI VRON-0200 alone and in combination with investigational antivirals for participants with chronic hepatitis B virus infection receiving stable nucleos(t)ide therapy: a phase 1b, randomised, open-label, multicentre trial. The Lancet. Microbe Bonhomme M, Currie S, Gane E, Lim TH et al. 2026-05-29 Sponsor
42213313 · DOI Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial. Hepatology international Cai X, Chen C, Chen Y, Cheng J et al. 2026-05-29 Sponsor
42216253 · DOI Flight of the dragons: a global review of migration in Odonata. Biological reviews of the Cambridge Philosophical Society Chapman JW, Hayward A, Hedlund JSU, Menz M 2026-05-29 Sponsor
42215489 · DOI An open multi-center MEG-EEG dataset for studying conscious visual perception. Scientific data Bonacchi N, Brown T, Das D, Ferrante O et al. 2026-05-29 Sponsor
42209879 · DOI Multiscale feature fusion for few-shot medical image learning with fisher information-driven layer selection. Visual computing for industry, biomedicine, and art Chen X, Pang B, Peng Y, Zhang K 2026-05-29 Sponsor
42209516 · DOI Superior dorsal nigral hyperintensity depiction at 7 T MRI using CLEAR-DESS improves diagnosis performance of Parkinson's disease. NPJ Parkinson's disease Bai HX, Chen R, He J, Hsu Y et al. 2026-05-28 Sponsor
42153573 · DOI Feedback loops between DNMT1 and autophagy as well as senescence promotes organ aging and canities. Autophagy Li L, Li LX, Li X, Liu H et al. 2026-05-28 Sponsor
42206348 · DOI Overcoming the Surface Instability Bottleneck in High-Mobility Crystalline Indium Oxide Thin-Film Transistors by Yttrium Oxide Stabilization. ACS nano Fan J, Ge Q, Ju S, Li J et al. 2026-05-28 Sponsor
42210008 · DOI SPP1 in Immunosuppressive Signaling in Lung Adenocarcinoma: Bulk and Single-Cell Transcriptomic Analysis. Cell biochemistry and biophysics Jiao L, Li F, Liu Y, Shi JX et al. 2026-05-28 Sponsor
42207433 · DOI Exploration of Real-World Data Sources in Latin America, Middle East and North Africa, and Asia Pacific, to Support Oncology Evidence Generation: A Targeted Literature Review and Regional Recommendations. Advances in therapy Bazarbashi S, Chiu A, Dreyer N, Ghai C et al. 2026-05-28 Sponsor
42209477 · DOI Author Correction: A ZFYVE21-Rubicon-RNF34 signaling complex promotes endosome-associated inflammasome activity in endothelial cells. Nature communications Barkestani MN, Fan M, Fang C, Geirsson A et al. 2026-05-28 Sponsor
42207228 · DOI A multisociety consensus statement on a new common definition and diagnostic criteria for PSVD or NCPF. Hepatology international Alves VAF, Aqul A, Cerda E, Darwish Murad S et al. 2026-05-28 Sponsor
42207983 · DOI Staffing, Accepted Indications and Dose of Phase II Cardiac Rehabilitation: Country Income Class and Time-Based Comparisons from the International Council of Cardiovascular Prevention and Rehabilitation's (ICCPR) 2025 Audit Update. European journal of preventive cardiology Anchique CV, Batalik L, Botha NVH, Champaiboon J et al. 2026-05-28 Sponsor
42097137 · DOI Multi-cohort proteogenomic analyses reveal genetic effects across the proteome and diseasome. Cell Abbasi F, Assimes TL, Björck HM, Björkander S et al. 2026-05-28 Sponsor
42213858 · DOI Comparison of the EORTC QLQ-EN24, FACT-En, and FEnSI-23 for assessing quality of life in endometrial cancer: a systematic review. Current opinion in supportive and palliative care Bottomley A, Cella D, Chan AW, Chow E et al. 2026-05-28 Sponsor
42209725 · DOI Transcription-independent induction of rapid-onset senescence is integral to healing. Nature cell biology Cherfils-Vicini J, Dahlhoff M, Dworak H, Efraimoglou C et al. 2026-05-28 Sponsor
42207056 · DOI Impact of atopic dermatitis on education and career choices: the Scars of Life international study. The Journal of investigative dermatology Aslanian FP, Begolka WS, Burstein S, Demessant-Flavigny AL et al. 2026-05-28 Sponsor
42213789 · DOI Action and rest tremor map to distinct networks within the primary motor cortex. Cell reports Al-Fatly B, Fox MD, Goede LL, Horn A et al. 2026-05-28 Sponsor
42210642 · DOI Rapid Generation of Subject-Specific Human Models With Detailed Tissue Structures for Timely Individualized SAR Assessment. Magnetic resonance in medicine He J, Hu J, Huang Y, Li Z et al. 2026-05-28 Sponsor
42204304 · DOI Robust multicentre detection and classification of colorectal liver metastases on CT: application of foundation models. NPJ precision oncology Aichert A, Bobowicz M, Faggioni L, Francischello R et al. 2026-05-27 Sponsor
42202721 · DOI Withdrawal notice to "Relationship between coronary microvascular dysfunction (CMD) and left ventricular diastolic function in patients with symptoms of myocardial ischemia with non-obstructive coronary artery disease (INOCA) by cardiovascular magnetic resonance feature-tracking"[ClinRad 79(7) (July 2024) 536-543. Clinical radiology An J, Cao J, He Y, Kong H et al. 2026-05-27 Sponsor

Pre-prints from China-based Authors

Pre-prints whose corresponding-author institution mentions China or major Chinese cities. Leading-edge signal.

DOI / Platform Title Corresponding author + institution Category Posted Peer-reviewed?
biorxiv v7
10.1101/2025.06.27.661923
Functional coherence of bacterial ecospecies Sarah Lauren Svensson
Shanghai Institute of Immunity and Infection / Chinese Academy of Sciences
microbiology 2026-06-05 Published
medrxiv
10.64898/2026.06.04.26354880
Education/training for health workers/students on inclusive and gender-affirmative care for trans and gender-diverse people: a systematic review Jun Xia
Nottingham Ningbo GRADE Centre, School of Economics, University of Nottingham Ningbo, China
health policy 2026-06-05 Published
biorxiv
10.64898/2026.06.04.730176
Microfluidic-based high-throughput isolation enhances the recovery of novel strains and diversity from Arctic soil microbiome Li Liao
Polar Research Institute of China
microbiology 2026-06-04 Published
medrxiv
10.64898/2026.06.02.26354777
AIM-PrEP: AI-Agent Driven Multicenter Intervention to Improve PrEP Adherence and Health Monitoring Among Men Who Have Sex with Men (MSM)-Protocol of A Randomized Controlled Trial Junjie Xu
Clinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, China
hiv aids 2026-06-04 Published
medrxiv
10.64898/2026.06.02.26354716
The Surgical Assessment and Healthcare (SAH) Index: A Risk-Adjusted Framework for Surgeon-Level Quality Audit in Gastric Cancer Birendra Kumar Sah
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
health systems and quality improvement 2026-06-03 Published
biorxiv
10.64898/2026.06.03.729796
Discovery of ARQ-501 as a potent PafA inhibitor that elevates KatG levels to potentiate isoniazid in mycobacteria Qingxiang Sun
UESTC: University of Electronic Science and Technology of China
microbiology 2026-06-03 Published
medrxiv
10.64898/2026.05.30.26353749
A Radiologic Masquerade: Camrelizumab-Associated Breast Lesions That Mimic Progression Xiaoling Zhang
Sun Yat-sen University First Affiliated Hospital Department of Radiology Guangzhou, Guangdong, CN
radiology and imaging 2026-06-03 Published
medrxiv
10.64898/2026.06.02.26354684
Oxygen extraction fraction brain charts for human lifespan and application for brain disorders Yaou Liu
Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical R…
neurology 2026-06-03 Published
biorxiv
10.64898/2026.05.29.728625
Magnetically guided macrophage immunobots coordinate iron-metabolic cascades and immunogenic ferroptosis for tumor immunotherapy Immihan Ceren Yasa
Thrust of Robotics and Autonomous Systems & Thrust of Bioscience and Biomedical Engineering, The Hong Kong University of…
bioengineering 2026-06-02 Published
medrxiv
10.64898/2026.06.01.26354560
Association between maternal history of psychiatric disorders and the risk of cardiovascular disease in offspring up to early middle-age Tai Ren
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
cardiovascular medicine 2026-06-02 Published
biorxiv
10.64898/2026.05.27.728164
Engineering xylose metabolism for diverse polyhydroxyalkanoates synthesis in Halomonas TD Jian-Wen Ye
South China University of Technology
bioengineering 2026-06-01 Published
medrxiv v2
10.64898/2025.12.17.25342447
Levels and trends in fertility rates among adolescents aged 15-19 in 21 States and Union Territories in India from 1990 to 2050: A Bayesian Modelling Study Fengqing Chao
The Chinese University of Hong Kong, Shenzhen
public and global health 2026-06-01 Published
biorxiv
10.64898/2026.05.28.728359
The free-living wellspring of symbiotic nitrogen fixation in Bradyrhizobium Haiwei Luo
The Chinese University of Hong Kong
microbiology 2026-05-29 Published
biorxiv
10.64898/2026.05.27.728070
An SE(3)-equivariant Crystal Structure Prediction Framework for Prospective Identification and Development of Bioactive Nucleoside Self-Assembling Materials Han Wang
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, Chi…
bioengineering 2026-05-29 Published
medrxiv v4
10.1101/2025.04.13.25325764
Safety and Efficacy of Vesemnogene Lantuparvovec, an AAV-Based Gene Therapy in Young Children Under 24 Months with Spinal Muscular Atrophy in Low- and-Middle- Income Countries. Second Interim Report (August 2025). Austin T. Gao
Lantu Biopharma, Guangzhou, Guangdong Province, China
genetic and genomic medicine 2026-05-28 Published
biorxiv
10.64898/2026.05.22.725279
A biointegrated living brain stimulator evokes specific neural signalling Xuemin Du
Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS)
bioengineering 2026-05-27 Published
biorxiv
10.64898/2026.05.23.727373
An AI-agent-orchestrated grey-box Transformer framework for sparse pharmacokinetic curve reconstruction and pharmacometric model initialization Dongyang Liu
Drug Clinical Trial Center, Peking University Third Hospital, Beijing 100191, China; Institute of Medical Innovation, Pe…
pharmacology and toxicology 2026-05-27 Published
biorxiv
10.64898/2026.05.24.727447
BMSC-Laden PEGDA/HAMA Dual-Crosslinked Hydrogels with Distinct Stiffness Profiles for Osteochondral Defect Repair Xintao Zhang
Peking University Shenzhen Hospital
bioengineering 2026-05-27 Published
medrxiv
10.64898/2026.05.26.26354082
Disposable versus reusable gastroscope in observation and endoscopic mucosal resection performance: a non-inferiority trial. Xianhuan Yan
Daichuan Medical (Shenzhen) Co., Ltd.
gastroenterology 2026-05-27 Published
medrxiv v2
10.1101/2025.08.01.25332496
Association of COVID-19 with risks of all-cause and cause-specific mortality post-infection: A UK Biobank cohort study Hon-Cheong SO
The Chinese University of Hong Kong
infectious diseases 2026-05-27 Published
medrxiv
10.64898/2026.05.23.26353939
Frontier Large Language Models for Comprehensive Medication Review in CKD Patients with Polypharmacy: A Trap-Embedded Synthetic Benchmark Hsuan-Ming Lin
An Nan Hospital, China Medical University, Tainan, Taiwan
health informatics 2026-05-26 Published
medrxiv
10.64898/2026.05.23.26353923
Comparative Study on Image Quality of Deep Learning and Adaptive Statistical Iterative Reconstruction-V in Thin Layer CT of liver Lesions Jing Zhang
The second People's Hospital of Changzhou,The Third Affiliated hospital of Nanjing Medical University
radiology and imaging 2026-05-26 Published
biorxiv
10.64898/2026.05.20.726718
A Time-Sequenced Three-Drug-Loaded Microneedle Patch for the Prevention of Vein Graft Restenosis After Coronary Artery Bypass Grafting Bolin Wang
Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University
bioengineering 2026-05-25 Published
medrxiv
10.64898/2026.05.17.26353417
Identification of amino acid metabolism-related biomarkers in liver fibrosis: a transcriptomic analysis with experimental validation Zetong Liu
Northeastern University (China)
gastroenterology 2026-05-24 Published
medrxiv v9
10.1101/2025.10.21.25338475
Digital Registrar: A Schema-First Framework for Multi-Cancer Privacy-Preserving Pathology Abstraction via Local LLMs Kai-Po Chang
School of Medicine, China Medical University, Taichung, Taiwan
health informatics 2026-05-23 Published